Table 2.

Correlation of immunotherapy‐related genes and IPM risk score in early‐stage LUAD patients

Variable 1	Variable 2	Pearson correlation coefficient	p value
Risk score	CTLA4	0.1406689	0.004986
Risk score	PD‐L1	0.1628738	0.001127
Risk score	TIM−3	0.1874968	0.1511717
Risk score	LAG3	0.0623279	0.2153
Risk score	TIGIT	0.1085566	0.03058
Risk score	IDO1	−0.1572216	0.061676
Risk score	CD4	−0.2581735	1.823e‐07
Risk score	CD8A	−0.1381627	0.005826
Risk score	CD8B	−0.06999592	0.1639

Bold highlights the significant genes or parameters which are emphasized and discussed in the main manuscript.

Abbreviations: IPM, immune prognostic model; LUAD, lung adenocarcinoma.